Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002;4(1):R2.
doi: 10.1186/bcr419. Epub 2001 Nov 21.

BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

Victoria M Basham  1 , Julian M Lipscombe, Joanna M Ward, Simon A Gayther, Bruce A J Ponder, Douglas F Easton, Paul D P Pharoah
Affiliations

BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

Victoria M Basham et al. Breast Cancer Res. 2002.

Abstract

Background: The contribution of BRCA1 and BRCA2 to the incidence of male breast cancer (MBC) in the United Kingdom is not known, and the importance of these genes in the increased risk of female breast cancer associated with a family history of breast cancer in a male first-degree relative is unclear.

Methods: We have carried out a population-based study of 94 MBC cases collected in the UK. We screened genomic DNA for mutations in BRCA1 and BRCA2 and used family history data from these cases to calculate the risk of breast cancer to female relatives of MBC cases. We also estimated the contribution of BRCA1 and BRCA2 to this risk.

Results: Nineteen cases (20%) reported a first-degree relative with breast cancer, of whom seven also had an affected second-degree relative. The breast cancer risk in female first-degree relatives was 2.4 times (95% confidence interval [CI] = 1.4-4.0) the risk in the general population. No BRCA1 mutation carriers were identified and five cases were found to carry a mutation in BRCA2. Allowing for a mutation detection sensitivity frequency of 70%, the carrier frequency for BRCA2 mutations was 8% (95% CI = 3-19). All the mutation carriers had a family history of breast, ovarian, prostate or pancreatic cancer. However, BRCA2 accounted for only 15% of the excess familial risk of breast cancer in female first-degree relatives.

Conclusion: These data suggest that other genes that confer an increased risk for both female and male breast cancer have yet to be found.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary of the location of published mutations in BRCA2 identified in male breast cancer cases (red triangles, this study; purple triangles, other published studies).
See this image and copyright information in PMC

References

    1. Casagrande JT, Hanisch R, Pike MC, Ross RK, Brown JB, Henderson BE. A case-control study of male breast cancer. Cancer Res. 1988;48:1326–1330. - PubMed
    1. Rosenblatt KA, Thomas DB, McTiernan A, Austin MA, Stalsberg H, Stemhagen A, Thompson WD, Curnen MG, Satariano W, Austin DF, Isacson P, Greenberg RS, Key C, Kolonlel L, West D. Breast cancer in men: aspects of familial aggregation. J Natl Cancer Inst. 1991;83:849–854. - PubMed
    1. Anderson DE, Badzioch MD. Breast cancer risks in relatives of male breast cancer patients. J Natl Cancer Inst. 1992;84:1114–1117. - PubMed
    1. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. A systematic population based assessment of cancer risk in first degree relatives of cancer probands. J Natl Cancer Inst. 1994;86:1600–1608. - PubMed
    1. Storm HH, Olsen J. Risk of breast cancer in offspring of male breast-cancer patients [letter]. Lancet. 1999;353:209. - PubMed